The Drug Metabolism–Cytochrome P450 pathway was downregulated in tissue samples from recovered diabetic foot patients compared to those from the disease group, suggesting that the APOE+ subpopulation might influence the onset and progression of diabetes through this metabolic pathway. This evidence concerns the gene APOE and diabetes mellitus.